Appears On
Episode Appearances
Moonshots with Peter Diamandis · Apr 27, 2026
David Sinclair on the Longevity Pill, Age Reversal Timelines, and Updated Protocols | EP #250
“Developed OSK gene combination for epigenetic reprogramming; first PhD student to have drug enter human trials”
Epigenetic Reprogramming Technology (OSK genes, Yamanaka factors)Gene Therapy Delivery Systems (AAV, lipid nanoparticles, chemical small molecules)Small-Molecule Drug Development for Longevity
View Analysis